How are PIEDs used?
PIEDs are commonly administered by injection, taken orally in pill form, or applied to the skin.6
Effects of PIEDs
Use of any drug can have risks. It’s important to be careful when taking any type of drug.
PIEDs affect everyone differently, based on:
- size, weight and health
- whether the person is used to taking it
- whether other drugs are taken around the same time
- the amount taken
- the strength of the drug (varies from batch to batch)
- method of use (oral vs injection).
Because PIEDs belong to a range of different drug classes, their effects can differ quite a bit. The section below outlines the typical effects of the PIEDs most commonly used in Australia.
Insulin
Short-term effects:
- low blood sugar which can lead to headaches, tremors, sweatiness, dizziness and blurred vision
- extremely low blood sugar which can eventually lead to seizures, coma and death.3, 4, 7
The long‑term effects of insulin have primarily been studied in people with diabetes. There is currently limited evidence on its long‑term effects when used for performance and image enhancement.
Insulin-like growth factors (IGF-1):
Short term effects:
- low blood sugar which can lead to headaches, tremors, sweatiness, dizziness and blurred vision
- extremely low blood sugar which can eventually lead to seizures, coma and death.
Long term effects:
- temporary facial pain, weakness or paralysis
- joint and nerve damage
- increased risk of certain cancers4
Human growth hormone (hGH)
Short-term effects:
- low blood sugar
- high blood pressure
- water retention and bloating.3
Long-term effects:
- joint and nerve damage
- increased risk of diabetes
- increased risk of impotence (low libido or erectile dysfunction)
- osteoporosis (weak bones)
- liver damage
- cardiomyopathy (a weak heart).3, 4
Thyroid hormone
Short-term effects:
- rapid or irregular heartbeat
- feeling nervous, anxious and/or irritable
- enlargement of the thyroid gland in the neck.3
Long-term effects:
- reduced bone density and increased risk of osteoporosis
- vision problems
- cardiovascular issues (e.g. heart failure).3, 5
Clenbuterol
Short-term effects
- headaches
- tremors (especially hand shakes)
- cramps
- anxiety
- insomnia
- increased heart rate
- high blood pressure.3
Long-term effects
- cardiovascular issues (e.g. enlargement of the heart, sudden cardiac death)
- enlargement of the liver
- high blood sugar.3, 4, 8
Diuretics
Short-term effects
- dehydration
- cramps
- fatigue
Long-term effects
- abnormal heart rhythms.3
Overdose
The use of some PIEDs, like anabolic androgenic steroids and human growth hormones (hGH), doesn’t result in acute toxicity or overdose (when immediate harmful effects happen shortly after taking too much of a drug).
Prolonged non-medical use of these PIEDs – particularly at high doses – can result in serious long-term health consequences and may increase the risk of premature death.
But, you could overdose if you take a large amount of other PIEDs, like insulin or clenbuterol.3, 9 Overdose risk, as well as symptoms of an overdose, will depend on the type of PIED used.4, 7, 8
PIEDs like insulin and clenbuterol can cause death.
Call triple zero (000) and request an ambulance if you or someone else has any of the following symptoms (emergency services are there to help and can provide more instructions).
- nausea/vomiting
- blurred vision
- tremors
- fast heart rate
- confusion
- seizures.6, 9
Mixing with other drugs
PIEDs use often involves polypharmacy. This means more than one substance is used at the same time to enhance results, manage side effects, or achieve specific appearance or performance goals.10-12
This practice is commonly referred to as 'stacking' among people who use PIEDs. While stacking is often believed to improve outcomes, it can greatly increase the risk of health harms.10
People who use PIEDs are also more likely than the general population to use other illicit drugs, such as amphetamines, cannabis, GHB and cocaine.6, 10, 13
This is concerning because using more than one substance can increase the harms linked to each drug. It can also lead to unexpected and potentially serious interactions.
Using more than one drug or type of drug at the same time is also called polydrug use.14
More on Polydrug use
Polydrug use is a term for the use of more than one drug or type of drug at the same time or one after another. Polydrug use can involve both illicit drugs and legal substances, such as alcohol and medications.
Long-term effects
PIEDs and mental health
The use of some PIEDs has been found to have an impact on mental health.
People who use anabolic-androgenic steroids (AAS) are more likely than people who don’t use them to report mood swings, anxiety, depression, body dysmorphia disorder and self-harm/suicidal ideation.17-22
Recent findings suggest that using trenbolone, a type of AAS, may be linked to increased verbal aggression. But, it also highlights the current lack of research on how individual AAS may affect mental health.23
There is limited research on whether the use of other PIEDs may affect mental health.
Tolerance
There is limited research on whether people can develop a tolerance to PIEDs.
Over time, the effects of PIEDs may begin to level off. This is often due to the body’s natural limits on muscle growth, fat loss and hormone regulation.
Even with higher doses, the effect of PIEDs may slow down or become less noticeable. Rather than the body developing tolerance in the usual sense, people may experience diminishing returns, where increasing the dose may only lead to smaller effects.24, 25
Dependence
While PIEDs use does not cause physical dependence, individuals may develop a psychological reliance on them, often due to the confidence and self-esteem boost they can provide.26-28 This reliance can make it difficult to stop using PIEDs, especially when there's a fear of losing physique or performance levels.29
For those who become dependent, PIEDs use can begin to dominate thoughts, emotions, and daily activities.
Reducing harm
PIEDs should be used with a valid prescription for a specific medical condition and under the supervision of a healthcare professional.
Some substances commonly used as PIEDs, such as testosterone, insulin, and human growth hormone (hGH), can be appropriately prescribed for legitimate medical use.
For people considering using PIEDs, discussing options with a healthcare professional and accessing prescribed, pharmaceutical‑grade products may help reduce potential health risks.
If you choose to use PIEDs for non-medical purposes, it’s very important to take steps to minimise potential harm:
- If injecting:
- Always use new, sterile equipment and in a clean environment to reduce the risk of infections and transmission of blood-borne viruses. You can access free, sterile injecting equipment from local Needle and Syringe Programs (NSP).
- Avoid spot injecting into small muscles (e.g. biceps, calves, pectorals). This does not enhance local muscle growth and instead significantly increases the risk of complications.
- Rotate injection sites regularly to prevent tissue damage and reduce the risk of abscesses or scarring.
- Monitor your health: schedule regular health check-ups, including blood tests (e.g. liver and kidney function, lipid profile, hormone levels) and cardiovascular screening (e.g., echocardiogram) to detect any issues early.
- Take regular breaks: avoid continuous use of PIEDs. Taking regular breaks can help reduce long-term health risks and allow your body to recover.
- Avoid polydrug use: where possible, avoid using multiple PIEDs simultaneously, and do not mix them with illicit or pharmaceutical drugs. These combinations can lead to unpredictable effects and significantly increase the risk of harm.
- Be cautious with purchasing PIEDs from unregulated markets: PIEDs from unregulated sources may be counterfeit or contaminated.15, 16 The Steroid Checking Project highlights the widespread presence of substandard steroids in Australia and offers valuable information for safer use. The technical report provides further detail on the analysis of samples collected as part of this project between 2024 and 2025.
- Rely on trusted sources for information: Peer networks and online forums may provide inconsistent or inaccurate advice. Hi-ground offers reliable resources, including A Practical Primer on Safer Use of Anabolic Steroids and Other Performance Enhancing Drugs - a comprehensive harm reduction guide designed to support informed and safer use practices.
Withdrawal
Withdrawal refers to the symptoms that can occur when someone who is dependent on a drug, or who has used a drug regularly over time, stops or reduces their use.30
Withdrawal can include physical symptoms (such as headaches, or nausea) and psychological symptoms (such as anxiety, or depressed mood).30
PIEDs do not typically cause dependence in the same way as other psychoactive substances. However, after a period of regular use, reducing or stopping PIEDs can lead to withdrawal symptoms as the body adjusts to functioning without them.
Symptoms may include:
- fatigue and low energy
- reduced physical strength
- low mood.28
Symptoms will vary depending on the type of PIEDs and a person’s history of use - including how strong they are and how long they last.30
Withdrawal symptoms and times vary depending on PIED type, but often should settle down after a few days and mostly disappear after a few weeks.3
Pregnancy, breastfeeding and PIEDs
Some PIEDs can interfere with natural hormonal balance, which may lead to fertility problems in both males and females, and pose risk to foetal development.
To minimise harm, PIEDs use should be stopped before trying to conceive and avoided completely during pregnancy and breastfeeding.31, 32
Getting help
If your use of PIEDs is affecting your health, family, relationships, work, school, financial or other life situations, or you’re concerned about someone else, you can find help and support.
Call the National Alcohol and Other Drug Hotline on 1800 250 015 for free and confidential advice, information and counselling about alcohol and other drugs
Help and Support Services search
Find a service in your local area from our list. Simply add your location or postcode and filter by service type to quickly discover help near you.
If you're looking for other information or support options, send us an email at [email protected]
Path2Help
Not sure what you are looking for?
Try our intuitive Path2Help tool and be matched with support information
and services tailored to you.
It’s illegal to use, possess, manufacture, supply, or import PIEDs without a prescription or medical licence. The penalties vary for every Australian state and territory.33
Medical practitioners can only prescribe steroids for legitimate therapeutic purposes.33
In 2023, the Australian Needle Syringe Program Survey found that PIEDs were:
- the third most reported drug last injected nationally
- the second most common drug last injected among new starters – rising from 18% in 2019 to 26% in 2023.34
The use of PIEDs is also increasing in younger age groups, with 2.3% of Australian secondary school students reporting non-medical use in 2022-23.35
- Australian Crime Commission. Organised crime and drugs in sports. New generation performance and image enhancing drugs and organised criminal involvement in their use in professional sport. [Internet]. Canberra; 2013. [cited 2026 Feb 20] p. 47.
- National Drug and Alcohol Research Centre. Performance and Image Enhancing Drugs. [Internet]. Sydney, NSW: University of New South Wales; [cited 2026 Feb 20]
- New South Wales Ministry of Health. Performance and image enhancing drugs (PIEDs): The facts. 2023. [cited 2026 Feb 24]
- Larance B, Degenhardt L, Dillon P, Copeland J. Use of performance and image enhancing drugs among men: a review. [Internet]. Sydney, NSW: National Drug and Alcohol Research Centre, University of New South Wales. 2005. [cited 2026 Feb 24] p. 72. Report no. 232.
- Clifton-Bligh RJ, Gild ML, Handelsman DJ, Kinahan A, Stuart M. Thyroid hormone abuse in elite sports: The regulatory challenge. Journal of Clinical Endocrinology and Metabolism [Internet]. 2022. [cited 2026 Feb 24];107(9):e3562–e73.
- van de Ven K, Eu B, Jackson E, Han E, Gouda N, Simmonds P, et al. GP guide to harm minimisation for patients using non-prescribed anabolic-androgenic steroids (AAS) and other performance and image enhancing drugs (PIEDs). Sydney: Sydney North Health Network [Internet]. 2020. [cited 2026 Feb 20].
- Piatkowski T, Cox LTJ. Insulin is super dangerous if you don't know what you're doing: Situating the risks of insulin within the image and performance enhancing drug community. Drug and Alcohol Review [Internet]. 2024. [cited 2026 Jan 23];43(7):1976–84.
- Kumari S, Pal B, Sahu SK, Prabhakar PK, Tewari D. Adverse events of clenbuterol among athletes: a systematic review of case reports and case series. International Journal of Legal Medicine [Internet]. 2023. [cited 2026 Jan 23];137(4):1023–37.
- Bonney CF, Hatten B, Wang GS. Toxicity from unintentional pediatric ingestion of a performance-enhancing drug: A case report with review of clenbuterol toxicity and treatment. The Journal of Emergency Medicine [Internet]. 2019. [cited 2026 Feb 24];57(4):e105–e8.
- Piatkowski TM, Dunn M, White KM, Hides LM, Obst PL. Exploring the harms arising from polysubstance use among performance and image enhancing drug users among young Australian men. Performance Enhancement & Health [Internet]. 2021. [cited 2026 Feb 20];9(3):100197.
- Sagoe D, McVeigh J, Bjørnebekk A, Essilfie M-S, Andreassen CS, Pallesen S. Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis. Substance Abuse Treatment, Prevention, and Policy [Internet]. 2015. [cited 2026 Feb 20].
- Zahnow R, McVeigh J, Bates G, Winstock AR. Motives and correlates of anabolic-androgenic steroid use with stimulant polypharmacy. Contemporary Drug Problems [Internet]. 2020. [cited 2026 Feb 20].
- Skarberg K, Nyberg F, Engstrom I. Multisubstance use as a feature of addiction to anabolic-androgenic steroids. European Addiction Research [Internet]. 2009. [cited 2026 Feb 20];15(2):99–106.
- Darke S, Lappin J, Farrell M. The clinician's guide to illicit drugs and health [e-book]. Silverback Publishing; 2019 [cited 2026 Apr 22].
- Craven A, Ferris J, Nielsen S, Piatkowski T. Lead astray? The hidden contaminants in Australian anabolic–androgenic steroid market and their potential health impact. Drug and Alcohol Review [Internet]. 2025. [cited 2026 Feb 20].
- Vanhee C, Janvier S, Desmedt B, Moens G, Deconinck E, De Beer JO, et al. Analysis of illegal peptide biopharmaceuticals frequently encountered by controlling agencies. Talanta [Internet]. 2015. [cited 2026 Feb 26];142:1–10.
- Wenbo Z, Yan Z. The uses of anabolic androgenic steroids among athletes; its positive and negative aspects- A literature review. Journal of Multidisciplinary Healthcare [Internet]. 2023. [cited 2026 Feb 20];16:4293–305.
- Nackeeran S, Patel M, Nallakumar D, Deibert C, Ramasamy R. Anabolic-androgenic steroid use is associated with major depressive disorder and suicide attempt: analysis of a multi-national database. The Journal of Sexual Medicine [Internet]. 2022. [cited 2026 Feb 16];19(4):S48–S9.
- Lindqvist Bagge AS, Rosén T, Fahlke C, Ehrnborg C, Eriksson BO, Moberg T, et al. Somatic effects of AAS abuse: A 30-years follow-up study of male former power sports athletes. Journal of Science and Medicine in Sport [Internet]. 2017. [cited 2026 Feb 16];20(9):814–8.
- Havnes IA, Jørstad ML, Wisløff C. Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires. Substance Abuse Treatment, Prevention, and Policy [Internet]. 2019. [cited 2026 Feb 10];14(1):20.
- Ip EJ, Lu DH, Barnett MJ, Tenerowicz MJ, Vo JC, Perry PJ. Psychological and physical impact of anabolic-androgenic steroid dependence. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy [Internet]. 2012. [cited 2026 Feb 10];32(10):910–9.
- Bonenti B, Kerswell N, Shuttleworth G, Ganson KT, Ball L, Ferris J, et al. Mental health correlates of risky anabolic-androgenic steroid use in Australian alcohol and other drug treatment services. Drugs: Education, Prevention and Policy [Internet]. 2026. [cited 2026 Feb 26]:1–9.
- Piatkowski T, De Andrade D, Neumann D, Tisdale C, Dunn M. Examining the association between trenbolone, psychological distress, and aggression among males who use anabolic-androgenic steroids. International Journal of Drug Policy [Internet]. 2024. [cited 2026 Apr 10];134:104636. doi: https://doi.org/10.1016/j.drugpo.2024.104636.
- Bond P, Smit DL, de Ronde W. Anabolic-androgenic steroids: How do they work and what are the risks? Frontiers in Endocrinology [Internet]. 2022. [cited 2026 Feb 28];13.
- Santos HO, Haluch CEF. Downregulation of Androgen Receptors upon Anabolic-Androgenic Steroids: A Cause or a Flawed Hypothesis of the Muscle-Building Plateau? Muscles [Internet]. 2022.1(2):92–101.
- Keane H. Anabolic steroids and dependence. Contemporary Drug Problems [Internet]. 2003. [cited 2026 Feb 10];30(3):541–62.
- Yesalis C, Vicary J, Buckley W, Streit A, Katz D, Wright J. Indications of psychological dependence among anabolic-androgenic steroid abusers. Anabolic steroid abuse [e-book]. Vol.102. 1990 [cited 2026 Feb 20]; 196–214.
- Better Health Channel. Anabolic Steroids. 2024. [cited 2026 Feb 16]
- Scarth M, Westlye LT, Havnes IA, Bjørnebekk A. Investigating anabolic-androgenic steroid dependence and muscle dysmorphia with network analysis among male weightlifters. BMC Psychiatry [Internet]. 2023. [cited 2026 Feb 16];23(1):342.
- New South Wales Ministry of Health. Management of Withdrawal from Alcohol and Other Drugs: Clinical Guidance. [Internet]. 2022. [cited 2026 Apr 22] p. 105.
- Christou MA, Christou PA, Markozannes G, Tsatsoulis A, Mastorakos G, Tigas S. Effects of anabolic androgenic steroids on the reproductive system of athletes and recreational users: A systematic review and meta-analysis. Sports Medicine [Internet]. 2017. [cited 2026 Feb 24];47(9):1869–83.
- Cardoso RC, Padmanabhan V. Prenatal steroids and metabolic dysfunction: Lessons from sheep. Annu Rev Anim Biosci [Internet]. 2019. [cited 2026 Feb 15];7:337–60.
- Therapeutic Goods Administration. Performance and Image Enhancing Drugs. 2019. [cited 2026 Feb 17]
- Heard S, Maher L. Australian Needle Syringe Program Survey National Data Report 2019-2023: Prevalence of HIV, HCV and injecting and sexual behaviour among NSP attendees. [Internet]. Sydney: Kirby Institute, UNSW Sydney; 2024. [cited 2026 Feb 21]
- Scully M, Koh I, Bain E, Wakefield M, Durkin S. ASSAD 2022–2023: Australian secondary school students’ use of alcohol and other substances. [Internet]. Centre for Behavioural Research in Cancer: Cancer Council Victoria; 2023. [cited 2026 Feb 16]